Rutamarin
CAS: 13164-05-1
Ref. 3D-NAA16405
1mg | 436,00 € | ||
2mg | 621,00 € | ||
5mg | 1.044,00 € | ||
10mg | 1.739,00 € | ||
25mg | 3.913,00 € |
Informação sobre produto
- (+)-Rutamarin
- (2S)-2-[1-(Acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propen-1-yl)-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one
- 7H-Furo[3,2-g][1]benzopyran-7-one, 2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, acetate
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-,acetate (8CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-(9CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (S)-
- Chalepin acetate
- NSC 263654
- S-(+)-Chalepin acetate
- Ver mais sinónimos
Rutamarin is a low molecular weight inhibitor with a molecular weight of 567. It binds to the ATP binding site of the mitochondrial membrane, thereby inhibiting its function. Rutamarin inhibits the production of inflammatory mediators in vitro and in vivo by inhibiting cyclooxygenase-2 (COX-2) and the COX-2-dependent synthesis of prostaglandins. Rutamarin also causes a reduction in colorectal adenocarcinoma cells, as well as metabolic profiles that are associated with carcinomas. This drug also affects fatty acid metabolism, which may be due to its inhibition of peroxisome proliferator activated receptor (PPAR).
Propriedades químicas
Consulta técnica sobre: 3D-NAA16405 Rutamarin
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.